Impact of Glycosylation on Effector Functions of Therapeutic IgG †

By Abès Riad   Teillaud Jean-Luc  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 146-157

MDPI

Access to resources Recommend Favorite

In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)

By Nechansky Andreas   Koller Iris   Kircheis Ralf  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1887-1891

MDPI

Access to resources Recommend Favorite

Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein

By Mahmud Hafizah   Kasai Tomonari   Khayrani Apriliana Cahya   Asakura Mami   Oo Aung Ko Ko   Du Juan   Vaidyanath Arun   El-Ghlban Samah   Mizutani Akifumi   Seno Akimasa   Murakami Hiroshi   Masuda Junko   Seno Masaharu  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-02 ,pp. : 659-659

MDPI

Access to resources Recommend Favorite

IgG and IgA with Potential Microbial-Binding Activity Are Expressed by Normal Human Skin Epidermal Cells

By Jiang Dongyang   Ge Jing   Liao Qinyuan   Ma Junfan   Liu Yang   Huang Jing   Wang Chong   Xu Weiyan   Zheng Jie   Shao Wenwei   Lee Gregory   Qiu Xiaoyan  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-01 ,pp. : 2574-2590

MDPI

Access to resources Recommend Favorite

Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1

By Sochaj-Gregorczyk Alicja M.   Ludzia Patryk   Kozdrowska Emilia   Jakimowicz Piotr   Sokolowska-Wedzina Aleksandra   Otlewski Jacek  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1688-1688

MDPI

Access to resources Recommend Favorite